Leadership Change

Philadelphia – October 01, 2026 -- Children's Hospital of Philadelphia (CHOP) has officially installed Joseph Mitchell, MD, as President and Chief Executive Officer, succeeding Madeline Bell after her nearly four-decade tenure and 11 years as CEO.

Mitchell completes an 18-month transition after joining CHOP as President in April 2025

Mitchell spent the past year and a half working alongside CHOP leadership, clinicians, researchers and community partners ahead of taking full control of the nation's first children's hospital, an institution founded more than 170 years ago.

Singapore – October 01, 2026 -- Emerald Clinical Trials has appointed Michael Stibilj as Chief Executive Officer, effective October 01, 2026, tasking the 30-year CRO veteran with leading the next phase of growth for a platform that now spans more than 1,000 professionals across 40-plus countries and 70-plus locations.

Stibilj joins from six years as Chief Operating Officer at Novotech

Before Novotech, Stibilj served three years as CEO of PPC Group and spent 22 years at IQVIA in regional and global leadership roles, with operational experience across China, Singapore and Australia.

Appointment follows the acquisition of Hongyi Clinical Development Services

The deal combined Emerald with Hongyi to create a clinical development platform supporting sponsors from first-in-human trials through post-marketing across China, Asia-Pacific, Europe and the Americas.

San Diego – October 01, 2026 -- Halozyme Therapeutics (Nasdaq: HALO) has appointed James "Jim" Daly to its Board of Directors, returning a veteran biopharmaceutical commercial executive to help steer the company's drug-delivery technology expansion.

Daly rejoins board after prior tenure, bringing three decades of launch experience

Daly previously served on Halozyme's board and has held senior commercial leadership roles at Incyte Corporation, Amgen and Glaxo Wellcome/GlaxoSmithKline. He was Executive Vice President and Chief Commercial Officer of Incyte from 2012 to 2015, following a decade at Amgen where he most recently served as Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development. Earlier, he spent more than 16 years at Glaxo Wellcome/GlaxoSmithKline, including as Senior Vice President and General Manager of the U.S. respiratory business.

Chicago – – October 01, 2026 -- Cars.com Inc. (NYSE: CARS) has appointed Trent Ziegler as Chief Financial Officer-Designate, effective October 01, 2026, with formal succession to the CFO role on October 01, 2026.

Ziegler replaces Sonia Jain, who transitions to Executive Advisor through October 01, 2026

The staggered handover is designed to ensure an orderly transition of financial leadership at the automotive marketplace operator. Jain will remain available to the company in an advisory capacity for nearly five months following the formal changeover.

Hayward, Calif. – October 01, 2026 -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT) appointed Alexander Davern to its Board of Directors effective October 01, 2026, adding more than three decades of industrial and technology leadership experience to its governance ranks.

Davern spent nearly 30 years at National Instruments, rising through CFO, COO and CEO roles

During his tenure at National Instruments, Davern helped scale the company's operations across more than 50 countries, gaining direct oversight of finance, operations and global expansion in a technology-manufacturing environment.

Vancouver – September 30, 2026 -- Lode Gold Resources Inc. (TSXV: LOD; OTCQB: LODFF; X27: FR) has named Patrick W. Garretson as Senior Technical Advisor to its Fremont Gold Mine project in Mariposa, California, bringing 35 years of operational experience from South32, Newmont, Goldcorp, Barrick and BHP Billiton to the brownfield asset.

Garretson led feasibility work on South32's Hermosa Project in Arizona

Most recently, Garretson served as Project Lead for Technical Services and Feasibility Study at South32's Hermosa Project, overseeing the Taylor-Hermosa Feasibility Study through mine design, permitting and planning. He holds a B.Sc. in Geology from Fort Lewis College and is a member of the Geological Society of Nevada, Arizona Geological Society and AusIMM.

UNITED STATES – September 30, 2026 -- ProgenyHealth has appointed Melanie Bella to its Board of Managers and named Alec DiDonato as Chief Operating Officer, moves the maternity and NICU care management company says will support its national expansion.

Bella brings 25 years of Medicaid policy experience to the board

Bella, an Executive Advisor with Cressey & Company, previously chaired the Medicaid and CHIP Payment and Access Commission (MACPAC). She served as Executive Vice President of Policy and Duals Strategy at Cityblock Health, a value-based provider focused on Medicaid and dual-eligible populations, and was the first Director of the Medicare-Medicaid Coordination Office at the Centers for Medicare & Medicaid Services. She also served as Medicaid Director for the state of Indiana and holds an MBA from Harvard Business School and a bachelor's degree from DePauw University.

Englewood, Colo. – September 30, 2026 -- WideOpenWest (WOW!) has appointed Christopher Sikora as chief commercial officer, consolidating brand, marketing, sales, product, pricing and call center operations under a single newly expanded role reporting directly to CEO Frank van der Post.

WOW! Centralizes Commercial Functions Under New Executive Hire

The restructured position places digital, sales and customer experience operations under one leader as the fiber-broadband provider pursues what van der Post described as an ambitious transformation plan targeting market and revenue growth.

Kelowna, BC – September 30, 2026 -- Doseology Sciences Inc. (CSE: MOOD, OTCQB: DOSEF, FSE: VU70) has appointed Kareem Baalbaki as interim CEO, interim CFO and director, alongside Jeremy Wright as a new board director, replacing outgoing CEO Chris Jackson and CFO Chris Cherry, who have both resigned.

Baalbaki scaled a Canadian CPG operator's revenue fifteenfold before joining Doseology

Baalbaki previously served as Chief Supply Chain Officer at Revive Superfoods, where he helped grow the frozen CPG platform's annual revenue from approximately $10 million to $150 million. The Toronto-based executive holds more than a decade of operations and supply-chain experience, including restructuring underperforming businesses and advising boards on governance and organizational design. He holds a Master of Science in International Business from the University of Lincoln in the United Kingdom.

Point Pleasant, N.J. – September 30, 2026 -- Paladone WeCool has appointed Matthew Lauderbach as Product Development Director, bringing more than 25 years of toy design experience to the company's US operations.

Lauderbach brings leadership experience from Fisher-Price, Spin Master and Just Play

Lauderbach's career spans leadership roles at Fisher-Price, Spin Master, Skip Hop and Just Play, with expertise covering concept creation, design management, engineering and commercialization.

Executive says he was already a fan of the Compound Kings and iLY Sticker Maker lines

In his new role, Lauderbach said he had admired Paladone WeCool's product range prior to joining, citing the Compound Kings and iLY Sticker Maker product lines as examples of the company's approach to hands-on play.